Does vitamin D signaling help regulate intestinal barrier and mucosal immune function?

Vitamin D has biologically credible roles in gut epithelial and immune regulation, but serum 25-hydroxyvitamin D [25(OH)D] alone cannot assign causation for an abnormal “intestinal permeability” or barrier-related test.

Mechanistic evidence

• In T84 intestinal epithelial cells, calcitriol/VDR signaling reduced LPS-associated loss of transepithelial electrical resistance and dextran permeability, while preserving ZO-1, claudin-5, and occludin. VDR–HDAC11 interactions were implicated in reduced repression of tight-junction gene promoters.
• Mouse studies similarly associate vitamin D deficiency or VDR deletion with disordered claudin expression and greater permeability. These effects are not uniformly “barrier strengthening”: VDR also regulates pore-forming claudin-2 and claudin-15, which can increase paracellular transport.
• VDR signaling also modulates mucosal immune activity, including antimicrobial peptides and inflammatory cytokine responses. In a small Crohn’s-disease remission trial, 2,000 IU/day for 3 months increased LL-37, although this does not establish a general clinical benefit.

Human interpretation

• Lower 25(OH)D has been associated with higher zonulin and endotoxin in critically ill patients, consistent with coexisting low vitamin D status and barrier-related abnormalities. Acute illness, inflammation, gastrointestinal disease, diet, adiposity, season, medications, and reverse causation could explain this relationship.
• Biomarkers such as zonulin, endotoxin, anti-flagellin, and anti-LPS antibodies are indirect rather than definitive permeability measures. In colorectal-adenoma patients, 1,000 IU/day vitamin D3 raised 25(OH)D without appreciably changing anti-flagellin or anti-LPS biomarkers.

Clinical implications

• The Endocrine Society’s 2024 guideline does not endorse universal vitamin D sufficiency cutoffs or the former 30-ng/mL target. A below-optimal result should not be treated as an established explanation for abnormal barrier testing.

Bottom line

• Vitamin D/VDR signaling plausibly influences epithelial tight junctions and mucosal immunity, but low serum vitamin D does not prove it caused abnormal intestinal-barrier findings; alternative explanations and the limitations of the test itself remain central to interpretation.